Previous close | 3.3000 |
Open | 2.5500 |
Bid | 2.5000 |
Ask | 2.6500 |
Strike | 105.00 |
Expiry date | 2024-10-18 |
Day's range | 2.5500 - 2.5500 |
Contract range | N/A |
Volume | |
Open interest | 178 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Ionis (IONS) out-licenses the rights for its HAE drug to Otsuka in the Asia-Pacific region. The companies signed a similar deal last year granting Otsuka rights to market the drug in Europe.